Healthcare Sales & Marketing Network News: Intellipharmaceutics

Searching News Database: Intellipharmaceutics

HSMN NewsFeed - 24 Feb 2017
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage(R) XR
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 3 Feb 2017
Intellipharmaceutics Announces FDA Acceptance for Filing of NDA for Rexista(TM) (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Nov 2016
Intellipharmaceutics Submits New Drug Application for Rexista(R) (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Jan 2012
Intellipharmaceutics Appoints Vice President Business Development
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 10 Nov 2010
Intellipharmaceutics Appoints New CFO
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 12 Sep 2006
Elite Pharmaceuticals Provides Update on Company's Progress and Projected Milestones
Biopharmaceuticals

Return to NewsFeed

Additional items found! 1

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 1 additional stories matching:
Intellipharmaceutics
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.